Trial intelligence / Profile preview

CC-ICS: Predicting Corticosteroid Response in Chronic Cough

NCT05888350Completed

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Start
Apr 2023
Primary completion
Apr 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial in chronic cough comparing Foster treatment group with Placebo controlled group (2 arms). Primary endpoint: Cough Visual Analog Scale at 4 weeks. Started Apr 2023; status: completed.

02

Drugs

beclometasone dipropionate + formoterol
03

Conditions

chronic cough

Beyond the preview

Go deeper on NCT05888350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05888350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call